These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 116310)

  • 21. [Radiobiological analysis of the use of low-intensity irradiation doses in radiation therapy].
    Kurpeshev OK
    Med Radiol (Mosk); 1980 Aug; 25(8):68-74. PubMed ID: 6995780
    [No Abstract]   [Full Text] [Related]  

  • 22. What degree of accuracy is required and can be achieved in photon and neutron therapy?
    Mijnheer BJ; Battermann JJ; Wambersie A
    Radiother Oncol; 1987 Mar; 8(3):237-52. PubMed ID: 3107087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lyoluminescent tissue-equivalent dosemeter for pion therapy beams.
    Atari NA; Malik SR; Brenner DJ; Hilko R; Bradbury JN
    Phys Med Biol; 1983 May; 28(5):493-502. PubMed ID: 6408655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The suitability of negative pions for radiotherapy: 4 years preclinical research with the biomedical PiE3-beam at SIN.
    Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):185-92. PubMed ID: 116302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative aspects of repair of potentially lethal damage in mammalian cells.
    Iliakis G; Pohlit W
    Int J Radiat Biol Relat Stud Phys Chem Med; 1979 Dec; 36(6):649-58. PubMed ID: 317956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repair of potentially lethal damage in unfed plateau phase cultures of Ehrlich ascites tumour cells. I. Suspension cultures.
    Iliakis G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Apr; 37(4):365-72. PubMed ID: 6968721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the use of the pion stopping distribution and the lesion additivity concept for the calculation of effective doses in pion treatment planning.
    Lam GK
    Phys Med Biol; 1990 Jun; 35(6):731-40. PubMed ID: 2114647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the thermoluminescent dosimetry to a pion beam.
    Valley JF; Guérid A; Lerch P; Pache G; de Lima V; Vinckenbosch M
    Radiat Environ Biophys; 1979 Aug; 16(3):225-9. PubMed ID: 116307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that repair and expression of potentially lethal damage cause the variations in cell survival after X irradiation observed through the cell cycle in Ehrlich ascites tumor cells.
    Iliakis G; Nüsse M
    Radiat Res; 1983 Jul; 95(1):87-107. PubMed ID: 6683856
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status of clinical pion radiotherapy.
    Kligerman MM; Black WC; Yuhas JM; Doberneck RC; Bradbury JN; Kelsey CA
    Radiology; 1977 Nov; 125(2):489-92. PubMed ID: 910063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PIOTRON: initial performance, preparation and experience with pion therapy.
    von Essen CF; Blattmann H; Crawford JF; Fessenden P; Pedroni E; Perret C; Salzmann M; Shortt K; Walder E
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1499-509. PubMed ID: 6815138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment planning for negative pi-meson radiation therapy: simultaneous multi-port irradiation with the Stanford Medical Pion Generator (SMPG).
    Pistenma DA; Li GC; Fessenden P; White K; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1977; 3():315-23. PubMed ID: 96067
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term results of pion therapy at Los Alamos.
    von Essen CF; Bagshaw MA; Bush SE; Smith AR; Kligerman MM
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1389-98. PubMed ID: 3114189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of a negative pion beam for the irradiation of superifical nodules in cancer patients.
    Richman C
    Radiat Res; 1976 Jun; 66(3):453-71. PubMed ID: 819958
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of a dynamic rangeshifter for modifying the depth-dose distributions of negative pions.
    Amols HI; Liska DJ; Halbig J
    Med Phys; 1977; 4(5):404-7. PubMed ID: 409920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of negative pions on spermatogonial survival in the mouse.
    Lambert BE; Phipps ML; Coggle JE; Davies RW; Peel DM
    Br J Radiol; 1982 Feb; 55(650):147-50. PubMed ID: 7055662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arrest of irradiated G1, S, or G2 cells at mitosis using nocodazole promotes repair of potentially lethal damage.
    Iliakis G; Nüsse M
    Radiat Res; 1984 Aug; 99(2):346-51. PubMed ID: 6463212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The applicability of pions to cancer radiotherapy. I. Experimental measurements of the capture and absorption of pions in polymer].
    Maki T; Nakano M; Cho T; Yoshimura A; Yoshinaga H; Uehara S; Hoshi M; Nagoshi C; Onizuka Y; Konishi K
    J UOEH; 1983 Jun; 5(2):221-33. PubMed ID: 6679631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiobiology of pions at LAMPF.
    Raju MR; Tokita N
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(12):2133-6. PubMed ID: 7161165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of negative pi mesons on vascular permeability of brain in neonatal rats.
    Landolt R; Arn D; Blattmann H; Cordt I; Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):303-8. PubMed ID: 504563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.